Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1478
-
Total 13F shares, excl. options
-
1,019,661,172
-
Shares change
-
+1,484,625
-
Total reported value, excl. options
-
$63,734,090,725
-
Value change
-
+$29,422,887
-
Put/Call ratio
-
1.41%
-
Number of buys
-
487
-
Number of sells
-
-886
-
Price
-
$62.55
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2018
1,711 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2018.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,478 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,019,661,172 shares
of 1,240,722,841 outstanding shares and own 82.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (104,186,077 shares), Vanguard Group Inc (100,414,250 shares), Capital Research Global Investors (72,548,789 shares), STATE STREET CORP (56,115,444 shares), Bank of New York Mellon Corp (28,528,848 shares), Invesco Ltd. (19,748,136 shares), NORTHERN TRUST CORP (16,987,641 shares), GEODE CAPITAL MANAGEMENT, LLC (16,867,065 shares), DODGE & COX (16,520,430 shares), and Capital World Investors (15,022,664 shares).
This table shows the top 1478 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.